Literature DB >> 2982973

Resistance of seropositive volunteers to subcutaneous challenge with low-passage human cytomegalovirus.

S A Plotkin, R E Weibel, G Alpert, S E Starr, H M Friedman, S R Preblud, J Hoxie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2982973     DOI： 10.1093/infdis/151.4.737

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  5 in total

1.  Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression.

Authors:  S Pepperl; J Münster; M Mach; J R Harris; B Plachter
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 2.  The history of vaccination against cytomegalovirus.

Authors:  Stanley Plotkin
Journal:  Med Microbiol Immunol       Date:  2015-03-20       Impact factor: 3.402

3.  Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.

Authors:  M R MacDonald; X Y Li; R M Stenberg; A E Campbell; H W Virgin
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

4.  Human cytomegalovirus induces stage-specific embryonic antigen 1 in differentiating human teratocarcinoma cells and fibroblasts.

Authors:  P W Andrews; E Gönczöl; B A Fenderson; E H Holmes; G O'Malley; S Hakomori; S Plotkin
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

Review 5.  Neutralization of Human Cytomegalovirus Entry into Fibroblasts and Epithelial Cells.

Authors:  Felix Wussow; Flavia Chiuppesi; Heidi Contreras; Don J Diamond
Journal:  Vaccines (Basel)       Date:  2017-10-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.